Vigil Neuroscience, Inc.
VIGLDelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted in 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Vigil Neuroscience, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Vigil Neuroscience, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Atlas Venture Opportunity Fund I, L.P. | 10% Owner | 0Indirect | Aug 7, 2025 | 0 |
| Atlas Venture Associates Opportunity I, L.P. | 10% Owner | 0Indirect | Aug 7, 2025 | 0 |
| Atlas Venture Associates Opportunity I, LLC | 10% Owner | 0Indirect | Aug 7, 2025 | 0 |
| Atlas Venture Fund XII, L.P. | 10% Owner | 0Indirect | Aug 7, 2025 | 0 |
| Atlas Venture Associates XII, LLC | 10% Owner | 0Indirect | Aug 7, 2025 | 0 |
| Atlas Venture Associates XII, L.P. | 10% Owner | 0Indirect | Aug 7, 2025 | 0 |
| Magovcevic-Liebisch Ivana | President and CEO | 0 | Aug 5, 2025 | 0 |
| Thistle Mary | Director | 0 | Aug 5, 2025 | 0 |
| Blanchard Cheryl R | Director | 0 | Aug 5, 2025 | 0 |
| Booth Bruce | Director | 0Indirect | Aug 5, 2025 | 0 |
| Bruhn Suzanne Louise | Director | 0 | Aug 5, 2025 | 0 |
| Ziolkowski Jennifer Lynn | Chief Financial Officer | 0 | Aug 5, 2025 | 0 |
| Vitorovic Stefan | Director | 0 | Aug 5, 2025 | 0 |
| Koenig Gerhard | Director | 0 | Aug 5, 2025 | 0 |
| Kaufmann Petra | Chief Medical Officer | – | Aug 5, 2025 | 0 |
| Gray David L. F. | Chief Science Officer | – | Aug 5, 2025 | 0 |
| Budd Haeberlein Samantha L. | Director | 0 | Aug 5, 2025 | 0 |
| Verni Christopher | General Counsel | 4,000 | May 7, 2024 | 0 |
| Silber Christopher | Chief Medical Officer | – | Aug 7, 2023 | 0 |
| Thackaberry Evan | SVP, Head of Early Development | 1,500 | Mar 3, 2023 | 0 |
| Papapetropoulos Spyridon | Chief Medical Officer | 4,000 | Nov 22, 2022 | 0 |
| Thorp Clay | Director | 1,556,030Indirect | May 17, 2022 | 0 |
| Cormorant Asset Management, LP | Other: Former 10% Owner | 616,786Indirect | Jan 13, 2022 | 0 |
| Chen Bihua | Other: Former 10% Owner | 616,786Indirect | Jan 13, 2022 | 0 |
| Cormorant Global Healthcare Master Fund, LP | Other: Former 10% Owner | 616,786Indirect | Jan 13, 2022 | 0 |
| Cormorant Private Healthcare Fund IV LP | Other: Former 10% Owner | 616,786Indirect | Jan 13, 2022 | 0 |
| Vida Ventures GP III, L.L.C. | 10% Owner | 11,536Indirect | Jan 11, 2022 | 0 |
| Vida Ventures III-A, L.P. | 10% Owner | 11,536Indirect | Jan 11, 2022 | 0 |
| Vida Ventures III, L.P. | 10% Owner | 11,536Indirect | Jan 11, 2022 | 0 |
| Northpond Ventures GP, LLC | 10% Owner | 1,382,978Indirect | Jan 11, 2022 | 0 |
| Northpond Ventures, LP | 10% Owner | 1,382,978Indirect | Jan 11, 2022 | 0 |
| Rubin Michael P. | 10% Owner | 1,382,978Indirect | Jan 11, 2022 | 0 |
| Northpond Ventures II GP, LLC | 10% Owner | 1,382,978Indirect | Jan 11, 2022 | 0 |
| Northpond Ventures II, LP | 10% Owner | 1,382,978Indirect | Jan 11, 2022 | 0 |
| Amgen Inc | 10% Owner | 3,206,281 | Jan 11, 2022 | 0 |
| Alexandria Venture Investments, LLC | 10% Owner | 192,973 | Jan 11, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2024 (view filing) | Dec 19 | Same day | Budd Haeberlein Samantha L.Director | PPurchase | +12.0K | $1.71 | +$20.5K | New position12.0K after | |
| Dec 19, 2024 (view filing) | Dec 19 | Same day | Magovcevic-Liebisch IvanaPresident and CEO | PPurchase | +5.00K | $1.68 | +$8.40K | +2.3%222.7K after | |
| Dec 18, 2024 (view filing) | Dec 18 | Same day | Magovcevic-Liebisch IvanaPresident and CEO | PPurchase | +5.00K | $1.67 | +$8.35K | +2.4%217.7K after | |
| Dec 5, 2024 (view filing) | Dec 5 | Same day | Magovcevic-Liebisch IvanaPresident and CEO | PPurchase | +5.00K | $2.34 | +$11.7K | +2.4%212.7K after | |
| Nov 20, 2023 (view filing) | Nov 20 | Same day | Magovcevic-Liebisch IvanaPresident and CEO | PPurchase | +4.00K | $3.75 | +$15.0K | +2.0%207.7K after | |
| Nov 22, 2022 (view filing) | Nov 18 | 4 days | Papapetropoulos SpyridonChief Medical Officer | SSale | −300 | $14.00 | −$4.20K | −7.0%4.00K after | |
| May 17, 2022 (view filing) | May 16-17 | 1 day | Thorp ClayDirector | PPurchase | +36.7K | $2.85 | +$104.4K | +2.4%1.56M after | 2 lots |
| May 6, 2022 (view filing) | May 5 | 1 day | Thackaberry EvanSVP, Head of Early Development | PPurchase | +1.50K | $4.00 | +$6.00K | New position1.50K after | |
| May 4, 2022 (view filing) | May 3 | 1 day | Verni ChristopherGeneral Counsel | PPurchase | +4.00K | $3.77 | +$15.1K | New position4.00K after | |
| May 4, 2022 (view filing) | May 2-3 | 2 days | Magovcevic-Liebisch IvanaPresident and CEO | PPurchase | +5.00K | $3.68 | +$18.4K | +2.5%203.7K after | 2 lots |
| May 4, 2022 (view filing) | May 3 | 1 day | Ziolkowski Jennifer LynnChief Financial Officer | PPurchase | +4.00K | $3.77 | +$15.1K | New position4.00K after | |
| May 4, 2022 (view filing) | May 3 | 1 day | Papapetropoulos SpyridonChief Medical Officer | PPurchase | +4.00K | $3.40 | +$13.6K | New position4.00K after | |
| Mar 28, 2022 (view filing) | Mar 28 | Same day | Thorp ClayDirector | PPurchase | +3.00K | $7.20 | +$21.6K | New position3.00K after | |
| Jan 11, 2022 (view filing)9:18 PM ET | Jan 11 | Same day | Vida Ventures GP III, L.L.C. and 2 others10% Owner | PPurchase | +1.68M | $14.00 | +$23.4M | New position11.5K after | 2 lotsDuplicate filing |
| Jan 11, 2022 (view filing)9:15 PM ET | Jan 11 | Same day | Atlas Venture Opportunity Fund I, L.P. and 5 others10% Owner | PPurchase | +535.0K | $14.00 | +$7.49M | +12.5%4.81M after | Duplicate filing |
| Jan 11, 2022 (view filing)8:18 PM ET | Jan 11 | Same day | Northpond Ventures GP, LLC and 4 others10% Owner | PPurchase | +355.0K | $14.00 | +$4.97M | +34.5%1.38M after | |
| Jan 11, 2022 (view filing) | Jan 11 | Same day | Thorp ClayDirector | PPurchase | +265.0K | $14.00 | +$3.71M | +21.1%1.52M after | |
| Jan 11, 2022 (view filing) | Jan 11 | Same day | Booth BruceDirector | PPurchase | +535.0K | $14.00 | +$7.49M | +12.5%4.81M after | |
| Jan 11, 2022 (view filing) | Jan 11 | Same day | Vitorovic StefanDirector | PPurchase | +1.68M | $14.00 | +$23.4M | New position11.5K after | 2 lots |